BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ischemia
,
Neuron
,
Holistic medicine
,
Quercetin
,
rs2476601
,
NEUROG3
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
tumor- antibodies
Summary
General Info
Curated Studies
Most Correlated Studies
GSK cancer cell line transcript profiling
Drug target sets for approved compounds
Bladder cancers grouped by outcome, stage, invasion and gene expression profiling
Treatment of human Non-Hodgkins Lymphoma cell lines with agonistic antibodies
Chronic lymphocytic leukemia (CLL) tumors: progressors and non-progressors
Explore Curated Studies Results
Literature
Most Relevant Literature
Tumor-reactive antibodies evolve from non-binding and autoreactive precursors.
Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor …
B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid …
Tumor-Reactive Antibodies Emerge from Nonbinding and Autoreactive Precursors.
CTLA-4 inhibition facilitates follicular T and B cell interaction and the production of tumor-specif…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Combination of CAR-DC Vaccine and Anti-PD-1 Antibody in Malignant Tumors
FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors
Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease (IT-P…
Phase 1 Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Solid Tumors
Safety Study to Determine the Appropriate Dose of Antibody Against Tumor Cells to Best Target Patien…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ